Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era.

Dermatol Ther

Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari, Bari, Italy.

Published: July 2020

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267636	PMC
http://dx.doi.org/10.1111/dth.13499	DOI Listing

Publication Analysis

drug reaction

reaction eosinophilia

eosinophilia systemic

systemic symptoms

symptoms syndrome

syndrome hydroxychloroquine

hydroxychloroquine drug

drug spotlight

spotlight covid-19

covid-19 era

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!